Swapnil Khope
About Swapnil Khope
Swapnil Khope is an Associate Scientist at Bristol-Myers Squibb in Bangalore and a Principal Scientist at IDRS Labs Private Limited.
Current Position at Bristol-Myers Squibb
Swapnil Khope currently holds the position of Associate Scientist at Bristol-Myers Squibb. He is based in Bangalore, Karnataka, India. In this role, he is involved in various scientific research projects, contributing his expertise in pharmaceutical sciences. His work at Bristol-Myers Squibb plays a crucial part in supporting the company's research and development initiatives.
Role at IDRS Labs Private Limited
Currently, Swapnil Khope serves as the Principal Scientist at IDRS Labs Private Limited. He started this position in April 2018. In his capacity as a Principal Scientist, he leads important research projects and oversees scientific investigations, utilizing his extensive background in pharmaceutical sciences to drive innovation and discovery within the company.
Previous Experience at Aurigene Discovery Technologies
Before his current roles, Swapnil Khope worked as a Research Associate at Aurigene Discovery Technologies. His tenure lasted for two years, from 2010 to 2012. During this period, he gained valuable experience in research methodologies and contributed to various projects within the company, laying the foundation for his career in pharmaceutical sciences.
Educational Background in Pharmaceutical Sciences
Swapnil Khope has a well-rounded educational background in pharmaceutical sciences. He holds a Bachelor's degree in Pharmacy from the University Department of Pharmaceutical Sciences, Nagpur. Additionally, he has achieved a Master of Science degree from an undisclosed institution, further enhancing his expertise and knowledge in the field.
Professional Experience in Pharmaceutical Companies
Swapnil Khope has substantial experience working in both private and multinational pharmaceutical companies. His career includes significant roles at IDRS Labs Private Limited, Bristol-Myers Squibb, and Aurigene Discovery Technologies. This diverse experience has provided him with a broad perspective and deep understanding of the pharmaceutical industry.